Streptococcus pyogenes, the Group A Streptococcus (GAS), is the most common cause of bacterial pharyngitis in children and adults. Innate and adaptive host immune responses are fundamental for defense against streptococcal pharyngitis and are central to the clinical manifestation of disease. Host immune responses also contribute to the severe poststreptococcal immune diseases that constitute the major disease burden for this organism. However, until recently, little was known about the host responses elicited during infection. Cellular mediators of innate immunity used during host defense against GAS include epithelial cells, neutrophils, macrophages, and dendritic cells (DCs), which are reported to secrete a number of soluble inflammatory mediators, such as antimicrobial peptides (AMPs); eicosanoids, including PGE 2 and leukotriene B4 (LTB 4 ); chemokines; and proinflammatory cytokines. Th1 and Th17 responses play significant roles in adaptive immunity in both murine models of GAS pharyngitis and in human tonsil tissue.
Approximately 10-20% of school-age children are asymptomatic carriers of GAS. 7, 8 Upon etiologic diagnosis of an active infection, usually by rapid antigen-detection tests and/or throat culture, antibiotic treatment is used to reduce the severity and duration of pharyngitis symptoms, as well as to limit disease spread, suppurative complications (peritonsillar or retropharyngeal abscess, cervical lymphadenitis, sinusitus, otitis media, and mastoiditis), and development of ARF. 9 Penicillin is the treatment of choice for GAS pharyngitis, as a result of its efficacy and low cost. 10 There is no preventative vaccine against GAS currently available, although multiple vaccine candidates are in clinical and preclinical development. 11 A better understanding of immunologic responses that are effective against GAS could lead to host-directed preventative or therapeutic regimes.
Previous studies on GAS-related immune responses have largely focused on those elicited during invasive GAS infections, where severe morbidity and mortality may result from failure to control bacterial infection. 12 The findings from such studies are not necessarily reflective of immune responses elicited during superficial GAS infections, such as pharyngitis and impetigo, and indeed, the molecular and cellular bases of host immune responses to superficial GAS infections are comparatively less well understood. Although GAS is exclusively a human pathogen, several animal models that at least partly mimic human GAS pharyngitis have been established. [13] [14] [15] Murine nasopharyngeal infection models are most commonly used, with mice being inoculated with GAS under each nostril. In this model, GAS colonizes the NALT, which is functionally equivalent to the human palatine tonsil. 15 Such models have allowed the analysis of immune responses that are associated with either host protection or susceptibility. For example, transgenic expression of the human MHC-II molecules HLA-DR4 and HLA-DQ8 in mice promoted acute nasopharyngeal GAS infection, suggesting that MHC-II molecules contribute to the human-specific tropism of a GAS serotype M18 strain. 16 This was mediated, at least in part, by the GAS superantigen SpeA, suggesting a possible role for GAS superantigens during human colonization.
In addition to mouse models, several (usually immortalized) cell lines have been used to examine GAS-induced inflammatory responses. In vitro studies have been useful in investigating the immune response of individual cell types following GAS infection; however, the variety of cellular models used, as well as the dearth of studies in primary cells, makes the interpretation of such findings complex.
Much of this work has also been done with nonpharyngeal-derived cell lines, such as HEp-2 (HeLa derivative epithelial cells from cervix) and HaCaT (skin keratinocytes), which may not respond in the same way as pharyngeal cells to GAS infection. Fortunately, follow-up studies that have used primary tonsil or pharyngeal-derived cells appear to be largely in agreement with studies that used nonpharyngeal cell lines for a wide number of immune mediators secreted in response to GAS infection, such as IL-6, TNF-, and IL-8 (Table 1 ). In addition, work using both human and murine cell lines has shown that the level of inflammatory mediators produced in response to GAS is often genotype (emm-type)-dependent, 17 -19 making results difficult to extrapolate for other emm types. In this review, we present the current state of knowledge on innate and adaptive immune responses elicited during GAS pharyngitis and discuss how these might influence the outcome of infection.
INNATE IMMUNE RESPONSE TO GAS PHARYNGITIS
As with other infections, the innate immune system plays an essential role in the early detection of GAS and subsequent initiation of proinflammatory responses. GAS pharyngitis is characterized by bacterial colonization of the palatine tonsil, a specialized lymphoid tissue that contains a number of cell types with innate immune defense roles, including epithelial cells, neutrophils, macrophages, and DCs (Fig. 1) . In response to GAS infection, these cell types secrete a number of inflammatory mediators (Table 1) , including cytokines, chemokines, AMPs, and PGs, as part of a highly coordinated host process. These mediators orchestrate the ensuing inflammatory response to GAS and also instruct the resulting adaptive immune response. Below, we discuss some of the key innate cell types and soluble mediators that have been examined in the context of GAS pharyngitis, as well as specific mechanisms by which GAS counteracts their actions.
Epithelial cells
The pharyngeal and tonsil epithelia are an important component of innate immune defense against GAS infection, primarily by acting as a physical barrier but also by secreting AMPs and cytokines/chemokines to signal to other immune cell mediators. GAS not only forms biofilms on the surface of the tonsillar epithelium but can also invade the epithelium to survive intracellularly. 20, 21 Primary human tonsil fibroblasts and single-cell suspensions of NALT or human tonsil cells secrete TGF-1 following exposure to GAS, which in concert with IL-6, secreted by GAS-infected epithelial cells and macrophages, drives CD4 + Th17 cell differentiation. 22,23 TGF-1 also regulates the expression of extracellular matrix proteins, including fibronectin and integrins, 24, 25 and TGF-1 signaling has been shown to enhance GAS invasion of epithelial cells, 23 suggesting that it may play a role in promoting bacterial colonization. In response to GAS infection, epithelial cells also secrete neutrophil chemoattractants, such as IL -8, 26 with this process likely to be an important protective mechanism elicited by epithelial cells during GAS pharyngitis. 19 
Neutrophils
Neutrophils, the most abundant type of leukocyte in the blood, rapidly infiltrate the NALT in a murine GAS nasopharyngeal infection model. 16 Neutrophils kill GAS by the release of AMPs through degranulation, phagocytosis, and phagolysosomal destruction of GAS by reactive oxygen species and the formation of NETs. 27 Repeated GAS infection or intranasal vaccination stimulates an IgA/IgG antibody and Th17 cellular response in mice, which dramatically enhances neutrophil recruitment and myeloperoxidase antimicrobial activity during early infection. 28 This is thought to be mediated by Th17 cell secretion of 
TA B L E 1 Host factors implicated in GAS pharyngitis
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Streptococcus pyogenes F I G U R E 1 Interplay between immune cells in the clearance of GAS within the tonsil, as well as GAS subversion mechanisms. Upon infection, GAS (red) colonizes and invades the tonsillar epithelium. Epithelial cells secrete bactericidal AMPs and neutrophil chemotactic factors, such as IL-8, whereas tissue resident macrophages phagocytose colonizing bacteria and produce TNF-, which in turn, activates neutrophils and monocytes. Upon GAS recognition, DCs promote Th1 maturation by the secretion of Th1-polarizing cytokines, such as IL-12, whereas epithelial cells and macrophages contribute to Th17 maturation by the secretion of the Th17-polarizing cytokines IL-6, TGF--1, and IL-1 . Th17 cells secrete IL-17A, which promotes epithelial cell-mediated recruitment and activation of neutrophils and macrophages. Th1 cells produce IFN-, which activates neutrophils and regulates neutrophil recruitment to the infection site but also contributes to bacterial carriage in the NALT. A number of GAS virulence factors have been characterized using in vivo models of GAS pharyngitis, which target soluble and cellular immune mediators to subvert infection (red text). SpyCEP cleaves IL-8, abrogating its chemotactic activity, whereas PerR is a peroxide response regulator that provides resistance to macrophage phagocytosis. The adhesin AspA is an anti-phagocytic factor that inhibits macrophage and neutrophil phagocytosis, and SpeB cleaves pro-IL-1 to produce mature IL-1 during infection, which enhances neutrophil recruitment. SIC binds to and inhibits secreted AMPs IL-17A, which stimulates the production of chemokines and cytokines, promoting the recruitment and activation of polymorphonuclear leukocytes, such as neutrophils, as well as macrophages. 29, 30 Indeed, a neutralizing antibody against IL-17A prevented GAS clearance from the NALT, 31 likely because of impaired leukocyte infiltration.
Several GAS virulence factors have been characterized to impair neutrophil recruitment and activity during infection. The bacteriophage-encoded GAS DNase (Sda1) protects GAS from neutrophil killing by degrading NETs, which are released by neutrophils to entrap and kill invading bacteria. 32 M1T1 is a globally disseminated clone of GAS that is frequently recovered from cases of streptococcal pharyngitis, 33 and an M1T1 Sda1 mutant showed reduced survival compared with wild-type strains in human neutrophil killing assays. 34 A DNase inhibitor also increased GAS sensitivity to neutrophil killing in vitro and in a murine model of necrotizing fasciitis, 32 indicating that Sda1 is essential for GAS resistance to neutrophils. SCPA cleaves murine and human polymorphonuclear leukocyte chemotactic factor C5a, and intranasal vaccination against SCPA generated serum IgG/IgA responses and prevented GAS nasopharyngeal colonization of mice. 35 In a murine air-sac model, SCPA mutant GAS were cleared more efficiently than wild-type GAS and induced the infiltration of significantly higher numbers of polymorphonuclear leukocytes, 36 suggesting that subversion of leukocyte recruitment is critical for GAS to establish an infection. Immunization with SpyCEP (or ScpC), which cleaves chemokines that attract phagocytes, including neutrophils, protected mice against nasopharyngeal infection. 37 A GAS knockout mutant lacking SpyCEP had significantly reduced survival compared with wild-type GAS in human neutrophil killing assays, 38 and SpyCEP expression also enhanced bacterial dissemination from the NALT to the lungs in mice. 39 SpyCEP expression by the commensal Lactococcus lactis enabled its survival in the nasopharynx, and whereas GAS expression of SpyCEP also contributed to its survival in the NALT, it was not essential, suggesting that other virulence factors expressed by GAS are able to compensate for SpyCEP. 39 In a murine soft-tissue model of GAS infection, the infiltration of polymorphonuclear leukocytes to the infection site was impaired, 40 with this effect being attributed to SpyCEP-mediated degradation of the polymorphonuclear leukocyte-attracting chemokine IL-8. In mice infected with SpyCEP-deficient GAS, polymorphonuclear infiltration was increased, and the infection was controlled. However, this strain caused a lethal infection in polymorphonuclear leukocyte-depleted mice, thus underscoring the importance of neutrophils in the innate immune response to GAS infection.
The hemolysins SLS and SLO are pore-forming toxins that induce osmotic lysis of a broad spectrum of host cells, including neutrophils. 41 GAS production of SLO is associated with human neutrophil lysis in vitro, with a reduction in neutrophil lysis observed following incubation with SLO mutant GAS. 42 SLS has also been shown to induce apoptosis of human neutrophils, with SLS mutant GAS inducing significantly lower levels of neutrophil apoptosis. 43 Elimination of neutrophils that encounter GAS, by the expression of cytotoxic virulence factors, such as SLO and SLS, is a mechanism the bacterium may use during pharyngeal infection to evade host innate immune responses. 
Mast cells
Macrophages
Tissue resident macrophages contribute to control of GAS infection by phagocytosis and the production of reactive oxygen species, while stimulating the recruitment of inflammatory monocytes and their differentiation to inflammatory macrophages at the site of infection.
Macrophages express a number of cytokines in response to GAS, including IL-6, TNF-, IFN-, and IL-8. 17,50 IL-6 contributes to the differentiation of Th17 cells from naive T cells during GAS infection, whereas TNF-recruits and activates many cell types, including neutrophils and monocytes. In a murine soft-tissue model of GAS infection, TNF-secretion by macrophages was required for monocyte recruitment to the site of infection. 51 TNF--deficient mice were impaired in monocyte infiltration, whereas systemic depletion of monocytes, using clodronate-containing liposomes, rendered mice sensitive to GAS infection, thus suggesting that monocytes and/or macrophages play an important role in resistance to GAS infection. The function of type I IFN signaling during GAS infection has currently only been investigated in invasive infection, where it plays an immunomodulatory role. Mice deficient for the Ifnar1 −/− had decreased survival following subcutaneous GAS infection, which was accompanied by increased neutrophil recruitment, as well as exaggerated destruction of infected tissues. 52 Another study showed that subcutaneous infection of Ifnar1 −/− mice with GAS was accompanied by elevated systemic levels of the proinflammatory cytokine IL-1 that exceeded the protective range. 53 Exogenous IFN-suppressed IL-1 gene expression and secretion from wild-type but not Ifnar1 −/− BMDMs, suggesting that type I IFN signaling is required to control M -expressed IL-1 to enable protective effects, rather than pathologic ones, during GAS infection. Supernatants from GAS-infected macrophages (containing CXCL9 and CXCL10) stimulated the migration of Th1 cells in vitro, 54 suggesting that macrophages are important for Th1 cell recruitment during infection. GAS infection of human macrophages also activated the Nlrp3 inflammasome (see below), leading to the secretion of the proinflammatory cytokine IL-1 . 55 This cytokine has a well-characterized role in promoting neutrophil recruitment; however, its function in the context of pharyngitis infection is not yet known.
Eicosanoids, such as PGE 2 and leukotrienes, are lipid mediators that play both proinflammatory and immunoregulatory roles in the innate immune response 56 and are known to regulate the capacity of macrophages to respond to GAS during infection. PGE 2 was produced by macrophages following GAS infection and suppressed the bactericidal activity of BMDMs in vitro by preventing the generation of reactive oxygen species. 57 This was attributed to PGE 2 -mediated accumulation of intracellular cAMP and activation of PKA, an endogenous suppressor of phagocytosis and reactive oxygen intermediate generation. 58 Treatment of BMDMs with PGE 2 or the PKA activator (S)-p-8-(-4-chlorophenylthio) adenosine-3 ′ ,5 ′ -cAMP enhanced bacterial survival, whereas treatment with the PGE 2 receptor EP2 inhibitor AH6809 or the PKA inhibitor (PKI [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] ) restored BMDM-mediated killing of GAS. 57 In contrast, LTB 4 is a potent stimulator of macrophage phagocytosis of GAS, and treatment of human macrophages with LTB 4 before GAS infection reduced intracellular cAMP levels and significantly increased macrophage phagocytic activity and intracellular bacterial killing. 59 Several mechanisms of GAS resistance to macrophage killing have been described in the literature. SLS and SLO induced oncotic cell death of BMDMs, with strains deficient in both SLS and SLO activity significantly more attenuated for cytotoxicity than singlemutant strains. 60 The peroxide response regulator PerR, which is thought to enhance GAS virulence by modulating bacterial responses in oxidative environments, appears to play a critical role in GAS resistance to macrophage phagocytosis, as well as virulence during pharyngeal infection. 61 Deletion of PerR was associated with reduced resistance to phagocytic killing by murine macrophages and to human blood leukocytes in vitro and attenuated GAS colonization in a baboon model of GAS pharyngitis. 61 The streptococcal AspA, which is required for GAS colonization of the nasopharynx by mediating adhesion to pharyngeal epithelial cells, is also an anti-phagocytic factor required for resistance to murine macrophage phagocytosis and neutrophil killing in vitro. Deletion of AspA results in increased susceptibility to macrophage phagocytic killing and failure of GAS (serotypes M2 and M28) to establish infection following intranasal challenge in mice, 62 suggesting that AspA plays an important role in GAS colonization and persistence in the pharynx. SpeB is known to facilitate evasion of autophagy and enhance GAS replication intracellularly by degrading host autophagy adaptor proteins 63 and has been shown to contribute to GAS survival within human macrophages from soft tissue infection biopsies. 64 SpeB-deficient GAS show decreased viability following infection of human macrophages in vitro, 64 suggesting that SpeB could contribute to immune evasion and bacterial persistence during GAS pharyngitis.
DCs
DCs are abundant in the pharynx, and these cells have key functions in priming T cell responses during GAS infection. The interaction of GAS with murine and human DCs in vitro induced DC maturation and the production of Th1-polarizing cytokines, such as IL-12. 65, 66 Selective depletion of CD11c + DCs in mice abolished GAS-induced IL-12 production and enhanced dissemination of GAS into the lymph nodes and liver from a localized subcutaneous infection. 65 IL-12 is known to stimulate NK cells to generate IFN-, 67 which is a classic macrophageactivating cytokine. 68 Whereas NK cells are implicated in the pathogenesis of GAS-invasive infections, where they are major sources of IFN-, IL-6, and IL-12, 69 the role of NK cells during GAS pharyngitis and superficial infections is currently not known. In a nasopharyngeal infection model, a significant decrease in CD11c + leukocytes was observed, which the authors hypothesized to be mediated by superantigen-mediated cytokine responses that induced immunosuppression, allowing GAS to escape myeloid cell-mediated killing. 16 As with findings in macrophages (see above), type I IFN signaling also appears to negatively regulate inducible IL-1 expression in DCs, thus limiting IL-1 -associated immunopathology. 52,53
PRRs and signaling pathways linked to GAS-initiated inflammatory responses
The host uses families of PRRs, such as the TLRs, to recognize and respond to highly conserved PAMPs that are displayed by invading microorganisms. Early studies demonstrated that the TLR adaptor protein MyD88 is required for GAS-mediated production of key cytokines; 70 from mice deficient in TLR1, TLR2, TLR4, or TLR9, TLR2/6 double-deficient mice, and TLR2/4/9 triple-deficient mice were still able to produce inflammatory cytokines following GAS infection. 73, 74 More recently, however, TLR2 and TLR13 were identified as GAS sensors, with knockout of both receptors required for abrogation of macrophage-mediated inflammatory responses to GAS in vitro. 50 TLR13, which is not present in humans, recognizes bacterial rRNA, 75 thus raising questions about possible species differences in innate immune recognition of GAS. However, another study showed that in human monocyte-derived macrophages, GAS RNA is recognized by TLR8, 76 a functional equivalent of TLR13. 77 TLR8 is located in endosomes of myeloid cells, such as monocytes, macrophages, and myeloid DCs, and its activation triggers the release of IL-6, TNF-, IFN-, and LL-37. 76, 78 Interestingly, TLR8 signaling has also been shown to induce autophagy, 78 a conserved cellular pathway that targets intracellular bacteria for lysosomal degradation. Of interest in this regard, autophagy plays a role in the defense of nonphagocytic cells against GAS in vitro, 79 and the suppression of the autophagy pathway has been implicated in the success of the globally disseminated GAS M1T1
clone. 63 Mice deficient in TLR2 or Unc93b1 (a trafficking protein required for endosomal TLR function) showed an increased susceptibility to GAS infection upon subcutaneous challenge, suggesting that both TLR2 and TLR13 are required for protective defense against GAS in mice. 50 GAS has also been shown to trigger non-TLR PRRs during infection by activating the Nlrp3 inflammasome. In response to endogenous and microbial stimuli, this signaling complex initiates caspase-1 activation, which drives the proteolytic processing of inflammatory cytokines, such as IL-1 and IL-18. 80 In response to live GAS expressing the virulence factor SLO, murine macrophages activate caspase-1 and secrete the proinflammatory cytokine IL-1 . 81 In contrast to these findings, extracellular NAD + -glycohydrolase, a SLOcoexpressed toxin, is reported to decrease inflammasome-dependent IL-1 release from infected macrophages, 82 suggesting that GAS is able to manipulate host cell secretion of IL-1 by multiple mechanisms. With the use of macrophages deficient in inflammasome components, it was shown that both Nlrp3 and apoptosis-associated speck-like protein containing a caspase activation and recruitment domain were crucial for caspase-1 activation and IL-1 secretion during GAS infection. The membrane-bound GAS virulence factor SpyA, an ADP-ribosyltransferase, has also been shown to stimulate caspase-1-dependent inflammatory responses and IL-1 production in murine macrophages, 83 whereas the GAS virulence factor SpeB has been proposed to function as an inflammatory caspase mimic to cleave pro-IL-1 to generate mature IL-1 . 84 This suggests that GAS can generate active IL-1 via multiple mechanisms. Another study using human macrophages showed that following stimulation with live or inactivated M1 GAS, inflammasome activation mediates the maturation of pro-IL-1 into mature-IL-1 . 55 Consistent with the inflammasome playing a protective role during GAS infection, BMDMs from caspase-1 −/− mice showed decreased survival and impaired killing of GAS. 83 Downstream inhibitors of these components blocked GAS-inducible expression of this AMP. 88 A transcriptome study of GAS-infected HEp-2 epithelial cells detected differential expression of the AP-1 transcription factor family members c-JUN and Fluoro-Jade B murine osteosarcoma viral oncogene homolog B, as well as activating transcription factor 3, 89 which interacts with AP-1. 90 This further implicates the MAPK-AP-1 signaling axis as a key mediator of GAS-regulated inflammatory gene expression. These signaling pathways lead to the production of numerous inflammatory mediators, the roles of which in GAS pharyngitis are discussed below.
PGE 2 and leukotrienes
Several studies have suggested a role for the eicosanoid PGE 2 during GAS pharyngitis. 57, 89, 91 and GAS, are known to induce PGE 2 production, which has inhibitory effects on immune cells, aiding in bacterial colonization of mucosal surfaces. 93 In response to GAS infection, HaCaT epithelial cells promote the secretion of PGE 2 . 91 BMDMs also secrete PGE 2 in response to GAS infection, 57 which is associated with decreased macrophage bactericidal activity, likely facilitating GAS colonization and survival during the early stages of infection.
Leukotrienes-another family of eicosanoid inflammatory mediators derived from arachidonic acid-have also been associated with GAS pharyngitis. LTB 4 has been reported to enhance proinflammatory responses to several pathogens, including GAS, by suppressing intracellular cAMP production in differentiated THP-1 macrophages, thus stimulating macrophage phagocytosis and intracellular killing. 59 A transcriptome analysis of pharyngeal infection in cynomolgus macaques detected a positive correlation between expression of the uncharacterized GAS transaldolase mipB and two genes encoding host leukotriene receptors, LTB 4 receptor (LTB4R) and CysLT receptor 2 (CYSLTR2). 94 Transaldolase is a key enzyme involved in carbohydrate metabolism, which is a cue for virulence gene expression in GAS, 95 suggesting that leukotriene signaling may enhance the proinflammatory responses to GAS virulence factors during infection. The role of leukotrienes during GAS pharyngitis now requires functional studies to investigate the cellular mediators and proinflammatory phenotypes that leukotrienes orchestrate during infection.
Chemokines
GAS has been reported to induce a plethora of chemokines from the pharyngeal-derived epithelial cell line Detroit 562, 96 54 In HLA-DR4 and HLA-DQ8 mice (a murine nasopharyngeal infection model), the profiling of nasal turbinates showed that a robust chemokine response was induced by the NALT. 16 The secretion of inflammatory chemokines was accompanied by the marked infiltration of neutrophils and appeared to be largely dependent on GAS superantigens, as a GAS-deletion strain for all 6 superantigen genes (encoding SpeA, SpeC, SpeG, SpeL, SpeM, and SmeZ) induced much lower levels of inflammatory chemokine secretion and only mild neutrophil infiltration.
Given the key role of chemokines in orchestrating leukocyte recruitment and host-protective immune responses, it is not surprising that GAS can combat their activities. GAS secretes several proteases that specifically cleave and inactivate various chemokines. SpyCEP cleaves and abrogates the activities of CXCL1, CXCL2, CXCL6, and IL-8, 39 thus impairing neutrophil recruitment and function. 99 During GAS lower respiratory tract infection in mice, an inverse relationship between the bacterial load and CXCL1 levels was observed, which was attributed to the protease activity of SpyCEP. 39 SpeB also cleaves a number of chemokines, including CXCL1, CXCL2, CXCL3, CXCL10, and CXCL11, and abolishes the chemotactic but not antimicrobial activity of CXCL9. 100 The activity of SpeB is required for GAS proliferation in human saliva, 101 as well as the dampening of the early host immune responses to establish skin infections. 102 As a result of SpeB cleavage of host chemokines that attract macrophages and neutrophils to the infection site, SpeB activity may potentially reduce the recruitment of specific cell types to the infection site and thus, enhance GAS survival and immune evasion during GAS pharyngitis.
Proinflammatory cytokines
Cytokines secreted during GAS pharyngitis signal in an autocrine and/or paracrine manner to instruct specific inflammatory responses during infection, with multiple studies investigating those cytokines released from different cell types. GAS infection of HEp-2 epithelial cells induced the secretion of IL-6 and TNF-18,89,103 and increased mRNA expression of RANTES, IL-1 , and IL-1 . 26 One study showed that M49 GAS infection of HEp-2 epithelial cells induced a significant proinflammatory response, with the authors speculating that this would lead to tissue destruction in vivo, thus allowing GAS to disseminate deeper into host tissues. 89 In response to GAS, HaCaT keratinocytes increased expression of mRNA for the cytokines IL-1 , IL-1 , and IL-6, 91 and HaCaT cells incubated with M1 protein released MIF, IL-1 , and IL-1Ra. 19 BMDMs are reported to secrete IL-6, TNF-, and IFN-in response to GAS, 17 and PBMCs secrete IL-1 , IL-6, TNF-, and IFN-. 104 Blood samples from patients with acute GAS pharyngitis showed high levels of the proinflammatory cytokines TNF-and IL-6 and reduced levels of the Th2 signature cytokines IL-4 and IL-10, suggesting that immune responses are skewed away from a Th2 phenotype. 105 In a murine nasopharyngeal GAS infection model, analysis of nasal turbinates revealed an early Th17-skewed response, with enhanced secretion of TNF-, IL-6, and IL-17A. 16 Other cytokines secreted included IL-1 , IL-1 , IL-2, LIF, and M-CSF. Despite these findings on individual cytokines produced during GAS infection, in many cases, their specific functions in host protection vs. susceptibility during GAS pharyngitis are still not well understood, as their roles have mainly been investigated using GAS-invasive disease models.
Multiple studies have identified IL-1 as a GAS-inducible cytokine. 81, 106, 107 Pro-IL-1 must be proteolytically processed to generate biologically active IL-1 that is secreted from cells, and IL-1 is critical in host defense against GAS-invasive infection, 3 which may be mediated by the ability of IL-1 to enhance the production of neutrophil chemoattractants. 108 In this respect, a recent study by LaRock et al. 84 found that the cysteine protease SpeB, which is secreted by the majority of disease-causing GAS strains, including the M1T1 strain 5448, 109,110 is able to generate mature and active IL-1 by proteolytic cleavage. This effect was not observed for another M1 GAS strain, which may reflect strain variation differences. 82 During invasive infection, GAS isolates often acquire mutations that down-regulate SpeB expression and therefore, reduce the capacity of such strains to cleave IL-1 . This presumably decreases IL-1 -mediated host responses. LaRock et al. 84 also hypothesized that the increased rate of invasive GAS disease observed in patients who receive the IL-1 inhibitor drug anakinra is therefore a result of a loss of host immunity in response to IL-1 , which would normally protect against the development of invasive GAS infection.
AMPs
AMPs are an important component of host innate defense against GAS infection, through both direct antimicrobial action at mucosal surfaces and chemokine-like immunomodulatory activities. 111 The bactericidal activity of AMPs against GAS has been investigated extensively. Primary human epithelia produce the HBDs, HBD2 and HBD3, which show bactericidal activity against GAS. 112 Human and mouse cathelicidins (LL-37 and cathelin-related antimicrobial peptide, respectively) are expressed in the skin and potently inhibit GAS bacterial growth. 113 The immunomodulatory activity of LL-37 has been widely studied in vitro, where it has been shown to stimulate IL-8 production by monocytes, as well as activate the AKT, CREB, and NF-B signaling pathways, leading to the expression of a number of cytokines and chemokines. 114 AMPs are often down-regulated by pathogenic bacteria to establish an infection. 115 Indeed, GAS infection of HaCaT keratinocytes reduced mRNA expression of genes encoding the AMPs HBD1 and HBD2. 116 Primary epidermal keratinocytes did not express HBD2 in response to GAS; however, HBD2 mRNA expression was restored in response to a CS101 GAS mutant lacking hyaluronic acid capsule expression (has mutant). 88 GAS also circumvents the antimicrobial activity of host AMPs by secreting the protein SIC and through the action of the cell wall-anchored M1 protein, which binds AMPs (including LL-37, human -defensin-1, HBD2, HBD3, lysozyme, and secretory leukocyte protease inhibitor) and prevents them from accessing the bacterial membrane. [117] [118] [119] [120] Inactivation of SIC resulted in decreased GAS proliferation in human saliva and significantly impaired colonization of the mouse oropharynx. 101, 121 GAS also secretes the plasminogen activator Ska, which activates host plasmin that can bind to the GAS surface, resulting in degradation of host LL-37. 122 Mutagenesis of the ska gene or proteolytic inhibition of plasmin reduced the virulence of GAS in a murine skin lesion-infection model, implying that the activity of LL-37 is important for controlling GAS infection at the epithelial surface. 122 Mechanisms of GAS resistance to LL-37 have also been reported, where subinhibitory concentrations of LL-37 induced the GAS CsrRS (also designated CovRS) two-component regulatory sys- 
The complement system
The complement system contributes to the opsonization of GAS for subsequent phagocytic killing, and a number of GAS virulence factors are reported to target components of the complement system during infection as an immune-evasion strategy. SCPA cleaves the complement component C5a, a potent polymorphonuclear leukocyte chemotactic factor, and intranasal vaccination against SCPA prevented GAS nasopharyngeal colonization in mice. 35 SIC inhibits complement-mediated formation of the MAC by blocking the membrane-insertion site on C5b-7, 126 and inactivation of SIC impaired M1 GAS colonization of the mouse oropharynx. 121 GAS, like all Gram-positive bacteria, is also resistant to MAC-dependent lysis. 127 The mechanism is thought to involve the thick peptidoglycan layer present in the cell wall of Gram-positive bacteria that prevents incorporation of the complex into the membrane and subsequent lysis. Whereas MAC ring structures are reported to form on the cell wall of GAS, the role of MAC in immune defense against GAS is unclear. 110 GAS M protein also plays a role in resistance to complement-mediated opsonophagocytosis by binding to complement-inhibitory proteins present in human serum, such as C4b-binding protein, 128 factor H, 129 and factor H-like protein 1. 130 M Protein also binds to other host proteins, such as fibrinogen, which inhibits complement C3 convertase deposition and provides resistance to phagocytosis by human blood leukocytes 131 and plasmin, which prevents deposition of the opsonin C3b and inhibits neutrophil phagocytosis of GAS. 132 
ADAPTIVE IMMUNITY DURING GAS INFECTION
A number of studies have investigated the role of acquired immunity in the clearance or protection against GAS pharyngitis. Patients lacking the innate signaling components MyD88 (a TLR adaptor) or the serine/threonine kinase IL-1 receptor-associated kinase 4 are susceptible to invasive and noninvasive pyogenic infections as children but become less susceptible with age. 133, 134 This suggests that the adaptive immune response, which develops throughout life, can compensate for innate immune deficiencies, and its role in protection against GAS infection is likely underestimated. Indeed, the majority of GAS pharyngitis cases occurs in children, whereas infection in adults is less common. 1 A recent study comparing the humoral and cellular adaptive immune responses of children and adults with conserved GAS antigens revealed that strong Th1 and Th17 cellular memory responses, IFNrelease, and an IgG1/IgG3-dominated humoral immune response develop in children following exposure to GAS. 135 Children showed significantly lower levels of IFN-and IgG3 than in adults, which may contribute to the higher GAS-infection rates that are observed in children. Thus, Th1-and/or Th17-biased responses are likely to play an important role in the development and preservation of GAS immunity over time (Fig. 1) . Tonsil explants from tonsillar hypertrophy and recurrent tonsillitis patients stimulated with heat-killed GAS also developed a Th1 cytokine response, with IL-1 , IFN-, and TNF-as the dominate cytokines secreted. 136 IFN-has been suggested to prevent the local dissemination of GAS in a murine NALT model 137 and is critical for protection against lethal skin infections in mice. 138 During GAS infections, TGF-1, produced by monocytes and DCs, was shown to be an essential driver of Th17 cell differentiation. 141 In addition, IL-6, secreted by a specialized CD301b + DC subset from cervical lymph nodes, 142 as well as epithelial-derived IL-6 and IL-23, also contributed to the development of this T cell response. 143 Although the precise mechanisms by which Th17 cells control GAS
infections are yet to be fully elucidated, IL-17A is well known to mediate the recruitment and expansion of neutrophils and macrophages, 141 key cell types that contribute to the detection and clearance of GAS. Interestingly, Th17-skewed CD4 T cell responses to GAS are dependent on intranasal inoculation, whereas intravenous or subcutaneous inoculation generated a Th1 response, with a characteristic IFNsignature. 142 In IL-6 −/− mice, IFN-+ CD4 T cells were expanded during GAS infection, and these mice were unable to clear the infection from the NALT and became long-term carriers. 142 This is likely because the IFN-+ CD4 T cells are unable to attract host-protective neutrophils to the infection site. This raises the intriguing possibility that an imbalance between IL-17A-and IFN--producing CD4 T cells could contribute to GAS carriage in humans. Th17 cells and IL-17A have been implicated in murine models of various GAS etiologies, such as chronic arthritis, acute sepsis, and puerperal sepsis. In a murine puerperal sepsis model, neutrophil recruitment and clearance of GAS were significantly attenuated in IL-17A −/− mice, 144 suggesting that IL-17A contributes to the control of GAS mucosal colonization. During acute sepsis, enhanced levels of IL-17A were detected in the serum of both sham-and GAS-infected mice within a short time of inoculation, indicating the speed and potency of the IL-17A response, which can be stimulated by trauma alone. 145 In a murine model of chronic arthritis, IL-17 receptor-deficient mice showed reduced joint destruction. 146 Mice deficient for IL-1 , which is required for the differentiation of 
PROTECTIVE ROLES OF PHARYNGEAL MICROBIOTA AGAINST GAS INFECTION
The normal microbiota that colonizes mucosal layers is an important component of first-line defense against invading pathogens, with commensal and probiotic bacteria competing with foreign microbes for niche and nutrients. Furthermore, initial studies showed that normal throat flora contains bacterial species (nonhemolytic streptococci, viridans streptococci, and Neisseria spp.) that are both inhibitory and bactericidal to GAS and can protect against GAS colonization in children. 153, 154 The microbiota can also regulate host immunity and contribute to host defense by modulating the cytokines and AMPs that host cells secrete. 155 In light of the evidence above, microbiota-mediated suppression of inflammation could potentially inhibit GAS growth and colonization of the tonsils. Proinflammatory cytokine production is often accompanied by increased epithelial permeability, as a result of perturbation of tight junctions, which GAS can exploit to gain access to host metabolites, adhesive factors, and underlying tissues. 159 Therefore, the ability of microbiota to dampen host proinflammatory responses is predicted to be beneficial in the control of GAS infections. Conversely, the antiinflammatory effects of microbiota could also contribute to asymptomatic and/or chronic bacterial carriage in children, where immune tolerance prevents the clearance of GAS. In addition, the ability of Lactobacilli to reduce SLS production suggests that microbiota may also play a role in regulating GAS virulence factor production to control bacterial colonization.
The oral microbiota can also protect against pathogenic bacterial infection by the secretion of bactericidal compounds, and BLIS K12
is a commercially available oral cavity probiotic that protects against GAS pharyngitis. 160 BLIS K12 is developed from Streptococcus salivarius K12, which is a bacterial species found in the oral microbiota of healthy humans. BLIS K12 antagonizes GAS growth by secreting the bacteriocins salivaricin A2 and B and has been shown to reduce GAS pharyngitis and/or tonsillitis episodes in children [161] [162] [163] and adults 164 who experience recurrent GAS infections. Given the widespread interest in microbiota-mediated immune regulation and control of disease outcomes, this will undoubtedly be an area of burgeoning interest in the future.
COMPLICATIONS ARISING FROM GAS PHARYNGITIS
GAS pharyngitis has been associated with the development of several disease pathologies, including autoimmune diseases. The pharynx is the primary site of infection of GAS, and from there, local complications can occur, such as peritonsillar or retropharyngeal abscess formation, as well as tonsillar hypertrophy. Autoinflammatory complications that may accompany pharyngitis infection can include scarlet fever, whereas postinfectious sequelae include ARF and GP. 165 
ARF and RHD
ARF and RHD are serious autoimmune diseases that can develop following GAS pharyngitis. These GAS-associated conditions have been reviewed extensively. [166] [167] [168] The pathogenesis of GAS infectioninduced, nonsuppurative pathologies remain elusive; however, they appear to be the result of an exaggerated immune response to specific GAS epitopes in susceptible individuals. 169 Clinical features of ARF include arthritis, carditis, and fever, and ARF episodes can occur recurrently. 170 RHD develops as a result of ARF and refers to the longterm damage of heart valves. 166 Prevention of these autoimmune conditions is best achieved through timely identification and antibiotic treatment of GAS pharyngitis. 171 
Scarlet fever
Scarlet fever is a skin rash that can be present during GAS pharyngitis. The rash typically appears within the first few days of GAS infection, spreading from the trunk to the extremities of the body. 165 The pathogenesis of scarlet fever is not well characterized; however, GAS secreted pyrogenic exotoxins have been implicated in evoking a rash in naïve subjects. No single toxin has been consistently associated with scarlet fever, but combinations of the exotoxins SpeA, SpeC, and streptococcal superantigen are often seen in GAS strains causing scarlet fever outbreaks. [172] [173] [174] [175] The mechanisms by which these exotoxins may contribute to the symptoms of scarlet fever are not well studied, but they have been found to alter IgG production and reticuloendothelial clearance function, induce T cell proliferation, and enhance skin reactivity. 176
Adenotonsillar hypertrophy and pediatric sleep apnea
GAS pharyngitis is associated with pediatric adenotonsillar hypertrophy (abnormal enlargement of the tonsil) and has recently been implicated in pediatric OSAS, which is primarily characterized by enlarged tonsils. 177 Tonsillar hypertrophy is caused by the proliferation of immune cells in the follicles and interfollicular areas of the tonsils in response to infection, and GAS was present in the tonsillar-reticulated crypt epithelium of 37% of children who had tonsillectomy for adenotonsillar hypertrophy. 8 The composition of immune cells in tonsils from recurrent GAS tonsillitis patients and from tonsillar hypertrophy patients is similar, and upon stimulation with GAS, both produce a Th1 cytokine response. 136, 147 A study by Viciani et al. 177 reported an association between OSAS and GAS tonsil colonization. These authors showed that the GAS toxin SLO induced production of CysLTs by a TLR4-mediated pathway that involved the TLR adaptors MyD88 and
Toll/IL-1R domain-containing adapter-inducing IFN-and p38 MAPK.
CysLTs activated primary T and B cell proliferation in vitro, which might mediate the development of tonsil hypertrophy and thus, pediatric OSAS. A second study by the same authors identified the GAS virulence factor SlaA, which is reported to target the CysLT production pathway to also be associated with OSAS. 178 The slaA gene was found in 45.5% of GAS strains isolated from OSAS patients. SlaA cleaves the fatty acids palmitic and oleic acids to release arachidonic acid, which is then converted to leukotrienes and CysLTs by the 5-lipoxygenase pathway and may contribute to tonsil hypertrophy and thus, OSAS. 179
GP
GP is an abnormal immune reaction characterized by the sudden onset of small, rounded skin lesions, caused by abnormal reactivity of specific T lymphocytes in the skin, leading to the infiltration of inflammatory cells and proliferation of keratinocytes. 180 GAS pharyngitis is often considered as a trigger of GP, and in 56-97% of GP cases, GAS pharyngitis precedes lesion formation. 181 The immunologic mechanisms that cause lesion formation are not well understood; however, Th17 responses are thought to play an important role. 182 Superantigens from GAS have been demonstrated to enhance T cell expression of CLA + , which is a carbohydrate-moiety expressed by 80% of T cells in the skin, and the abundance of CLA + CD8 + T cells in the blood of patients with psoriasis correlates with disease severity. 183 CLA + T cells in the tonsils and GP lesions of the same patient show identical TCR rearrangement (V 2 + ), suggesting that migration of these cells occurs from the tonsils to the skin. 184 Once in the skin, the CLA + T cells interact with lesional epidermal cells and induce a dominant Th17 response. 185 Some studies have reported that tonsillectomy results in improvement of psoriasis in the majority of cases and is associated with a reduction in the frequency of skin-homing T cells in the blood that were reactive to peptides derived from human epidermal keratins and streptococcal M proteins. 185, 186 The actual events that drive T cells to migrate from the tonsil to the skin and cause GP are not known. As GAS has been detected in the skin but not tonsils of patients with GP, it has been proposed that a transient presence of intracutaneous GAS during GAS pharyngitis could trigger autoimmunity against local skin proteins by molecular mimicry. 187 
CONCLUSIONS
GAS pharyngitis and resulting postimmune sequelae continue to cause a significant burden on human health globally, and an improved understanding of how the host immune system responds to GAS is important in developing better strategies to combat infection and disease. An The authors acknowledge support from the NHMRC researchgranting system.
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